BG104425A - 6,11-мостови еритромицинови производни - Google Patents

6,11-мостови еритромицинови производни Download PDF

Info

Publication number
BG104425A
BG104425A BG104425A BG10442500A BG104425A BG 104425 A BG104425 A BG 104425A BG 104425 A BG104425 A BG 104425A BG 10442500 A BG10442500 A BG 10442500A BG 104425 A BG104425 A BG 104425A
Authority
BG
Bulgaria
Prior art keywords
compound
formula
arylene
group
heteroarylene
Prior art date
Application number
BG104425A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yat S. Or
George Griesgraber
Leping Li
Daniel T. Chu
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG104425A publication Critical patent/BG104425A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG104425A 1997-10-29 2000-05-11 6,11-мостови еритромицинови производни BG104425A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
BG104425A true BG104425A (bg) 2001-01-31

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104425A BG104425A (bg) 1997-10-29 2000-05-11 6,11-мостови еритромицинови производни

Country Status (23)

Country Link
EP (1) EP1027361B1 (es)
JP (1) JP2001521038A (es)
KR (1) KR20010031591A (es)
CN (1) CN1278266A (es)
AR (1) AR015986A1 (es)
AT (1) ATE239750T1 (es)
AU (1) AU1286799A (es)
BG (1) BG104425A (es)
BR (1) BR9813317A (es)
CA (1) CA2307828A1 (es)
CO (1) CO4990972A1 (es)
DE (1) DE69814441T2 (es)
DK (1) DK1027361T3 (es)
ES (1) ES2198766T3 (es)
HU (1) HUP0004323A2 (es)
IL (1) IL134996A0 (es)
NO (1) NO20002099L (es)
PL (1) PL340253A1 (es)
PT (1) PT1027361E (es)
SK (1) SK6342000A3 (es)
TR (1) TR200001140T2 (es)
TW (1) TW486485B (es)
WO (1) WO1999021864A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
EP1430068A1 (en) 2001-09-17 2004-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
BR0214748A (pt) 2001-12-05 2004-11-23 Ortho Mcneil Pharm Inc Derivados 6-oacil-cetolidas de eritromicina, úteis como antibacterianos
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
KR100661973B1 (ko) 2002-05-13 2006-12-28 이난타 파마슈티칼스, 인코포레이티드 6,11 바이사이클릭 에리스로마이신 유도체
AU2003229037B8 (en) * 2002-05-13 2009-07-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
WO2018201076A2 (en) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
ATE239750T1 (de) 2003-05-15
CO4990972A1 (es) 2000-12-26
DE69814441T2 (de) 2004-04-08
EP1027361B1 (en) 2003-05-07
DK1027361T3 (da) 2003-08-25
AR015986A1 (es) 2001-05-30
NO20002099L (no) 2000-06-29
PT1027361E (pt) 2003-09-30
WO1999021864A1 (en) 1999-05-06
ES2198766T3 (es) 2004-02-01
CN1278266A (zh) 2000-12-27
CA2307828A1 (en) 1999-05-06
TW486485B (en) 2002-05-11
EP1027361A1 (en) 2000-08-16
JP2001521038A (ja) 2001-11-06
NO20002099D0 (no) 2000-04-25
IL134996A0 (en) 2001-05-20
KR20010031591A (ko) 2001-04-16
AU1286799A (en) 1999-05-17
SK6342000A3 (en) 2000-09-12
BR9813317A (pt) 2000-08-22
HUP0004323A2 (hu) 2001-02-28
DE69814441D1 (de) 2003-06-12
TR200001140T2 (tr) 2001-05-21
PL340253A1 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
US6046171A (en) 6,11-bridged erythromycin derivatives
BG104425A (bg) 6,11-мостови еритромицинови производни
CA2253338C (en) 6-o-substituted erythromycins and method for making them
US5780605A (en) 6,9-bridged erythromycin derivatives
AU737310B2 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
KR20010032688A (ko) 6-ｏ-알킬 에리트로마이신 ｂ 옥심
AU7447096A (en) Tricyclic erythromycin derivatives
PL191453B1 (pl) Związek ketolidowy, kompozycja farmaceutyczna go zawierająca, jego zastosowanie i sposób wytwarzania
US6420535B1 (en) 6-O-carbamate ketolide derivatives
EP1007530A1 (en) 6-o-substituted erythromycin compounds and method for making same
WO2003089447A1 (en) 5-o-mycaminosyltylonide derivatives
CA2301642A1 (en) 3-descladinose 6-o-substituded erythromycin derivatives
CA2378671C (en) 6-o-carbamate ketolide derivatives
JP2003501439A5 (es)
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním
MXPA00004227A (es) Derivados de eritromicina unidos en 6,11
SK160299A3 (en) Multicyclic erythromycin derivatives
MXPA00002216A (es) Derivados de eritromicina 6-o-substituida de 3-descladinosa
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
MXPA00003117A (es) Derivados de cetolido de eritromicina 6-0-substituida 3'-n-modificada que tienen actividad antibacteriana